Product Information
METHAMPHETAMINE 5 MG TABLET is a generic product labeled by Mayne Pharma, priced at $5.0978 per EA under NDC 68308011501. Its NADAC has been published 348 times since Jun 3, 2015.
FDA first approved this application on Apr 21, 2010. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/1
Manufacturer
Mayne PharmaNDC
68308011501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHAMPHETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091189FDA Approved
4/21/2010
TE Code
AA
On Market Since
4/26/2010
Pharmacological Classes
Price Statistics
The NADAC for METHAMPHETAMINE 5 MG TABLET has been published 348 times since Jun 3, 2015, and over the history we have for it it has risen 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0978 per EA |
|---|---|
| All-time high | $10.2282 (Mar 12, 2025) |
| All-time low | $3.2808 (Oct 21, 2015) |
| 52-week high | $6.7520 |
| 52-week low | $5.0978 |
| Median price | $5.9883 |
| Average price | $5.9687 |
| Largest weekly change | +78.8% (Sep 19, 2018) |
| Weeks tracked | 348 |
| Tracking since | Jun 3, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METHAMPHETAMINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHAMPHETAMINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHAMPHETAMINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAMPHETAMINE 5 MG TABLET, manufactured by Mayne Pharma, is $5.0978 per EA (NDC 68308011501), effective Sep 30, 2026.
How has the price of METHAMPHETAMINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAMPHETAMINE 5 MG TABLET has risen 36.3%. It has been tracked across 348 weekly CMS publications since Jun 3, 2015.
What are the highest and lowest recorded NADAC prices for METHAMPHETAMINE 5 MG TABLET?
Since Jun 3, 2015, the NADAC for METHAMPHETAMINE 5 MG TABLET has ranged from a low of $3.2808 (Oct 21, 2015) to a high of $10.2282 (Mar 12, 2025), with a median of $5.9883 per EA.
Are there cheaper alternatives to METHAMPHETAMINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METHAMPHETAMINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHAMPHETAMINE 5 MG TABLET?
METHAMPHETAMINE 5 MG TABLET (NDC 68308011501) is labeled by Mayne Pharma, and CMS classifies it as a generic product.